Advanced Search

Safinamide Stocks List

Symbol Grade Name % Change
NWPHF C Newron Pharms Spa Ord 0.00
VPHIF C Valeo Pharma Inc 0.00
View As Page of Charts
Related Industries: Biotechnology Drug Manufacturers—Specialty & Generic
Related Stock Lists: Drugs Pain Parkinson's Disease Psychoactive Drugs Treatment Of Parkinson's Disease Antiemetics Cancer Chemotherapy Diseases Gout High Blood Pressure Kidney Failure Liver Failure Medication Muscarinic Antagonists Nausea Pain Management Peripheral Nervous System Rett Syndrome Schizophrenia

Related ETFs - A few ETFs which own one or more of the above listed Safinamide stocks.

Symbol Grade Name Weight
View all Safinamide related ETFs...
Compare ETFs

    Recent Signals

    Date Stock Signal Type
    2021-04-13 VPHIF Fell Below 20 DMA Bearish
    2021-04-13 VPHIF Fell Below 50 DMA Bearish
    2021-04-13 VPHIF 180 Bearish Setup Bearish Swing Setup

    Recent News for Safinamide Stocks

    Date Stock Title
    Related Industries: Biotechnology Drug Manufacturers—Specialty & Generic
    Related Stock Lists: Drugs Pain Parkinson's Disease Psychoactive Drugs Treatment Of Parkinson's Disease Antiemetics Cancer Chemotherapy Diseases Gout High Blood Pressure Kidney Failure Liver Failure Medication Muscarinic Antagonists Nausea Pain Management Peripheral Nervous System Rett Syndrome Schizophrenia

    Safinamide (INN; brand name Xadago) is a drug used as an add-on treatment for Parkinson's disease during "off" episodes; it has multiple modes of action, including the inhibition of monoamine oxidase B.It was approved in Europe in February 2015, in the United States in March 2017, and in Canada in January 2019.

    More about Safinamide
    Browse All Tags